⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2489393 | 0.67 | — | — | |
| SCHEMBL13624526 | 0.67 | — | — | |
| SCHEMBL822279 | 0.67 | — | — | |
| SCHEMBL4523201 | 0.59 | — | — | |
| SCHEMBL22750847 | 0.59 | — | — | |
| SCHEMBL7686606 | 0.59 | — | — | |
| SCHEMBL7686604 | 0.59 | — | — | |
| SCHEMBL22750849 | 0.56 | — | — | |
| SCHEMBL4191405 | 0.56 | — | — | |
| SCHEMBL21494151 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1233944-B1 | COUPLING CONDENSATION SYNTHESIS OF HETEROCYCLES | MORPHOCHEM AG (DE) | 2004-03-31 | — | — | EP | claimed |
| CN-117440824-A | RNA vaccine against SARS-CoV-2 variants | 库瑞瓦格欧洲公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-116322758-A | Nucleic acid-based combination vaccine | 库尔维科欧洲股份公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116113430-A | Coronavirus vaccine | 奎尔法克股份有限公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-116096886-A | Compositions and methods for modulating fork-box P3 (FOXP 3) gene expression | 欧米茄治疗公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-112702994-A | Therapeutic nanoparticles and methods of use thereof | 根特大学 | 2021-04-23 | — | — | CN | disclosed |
| EP-3426714-B1 | BIODEGRADABLE CATIONIC POLYMERS AND USES THEREOF | THERMO FISHER SCIENTIFIC BALTICS UAB (US) | 2020-12-16 | — | — | EP | disclosed |
| US-20190048139-A1 | BIODEGRADABLE CATIONIC POLYMERS AND USES THEREOF | THERMO FISHER SCIENTIFIC BALTICS UAB (LT) | 2019-02-14 | — | — | US | disclosed |
| EP-3426714-A1 | BIODEGRADABLE CATIONIC POLYMERS AND USES THEREOF | Thermo Fisher Scientific Baltics UAB (US) | 2019-01-16 | — | — | EP | disclosed |
| WO-2017156447-A1 | BIODEGRADABLE CATIONIC POLYMERS AND USES THEREOF | THERMO FISHER SCIENTIFIC BALTICS UAB (US) | 2017-09-14 | — | — | WO | disclosed |
| CN-1894283-B | Reactive polysaccharide derivates, their preparation and their use | CIBA SC HOLDING AG | 2012-07-04 | — | — | CN | disclosed |
| EP-2388016-A9 | Non-viral nucleic acid molecules delivery systems | Ferruti, Paolo (IT) | 2012-01-04 | — | — | EP | disclosed |
| EP-2388016-A1 | Non-viral nucleic acid molecules delivery systems | Ferruti, Paolo (IT) | 2011-11-23 | — | — | EP | disclosed |
| US-PP22199-P2 | Crapemyrtle plant named ‘Gamad VII’ | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2011-10-18 | — | — | US | disclosed |
| CN-101849087-A | Method for reducing nitric oxide in the exhaust gas flow of internal combustion engines | MAN NUTZFAHRZEUGE AG | 2010-09-29 | — | — | CN | disclosed |
| EP-2215147-A2 | CLEAVABLE MODIFICATIONS TO REDUCIBLE POLY(AMIDO ETHYLENIMINE)S TO ENHANCE NUCLEOTIDE DELIVERY | University of Utah Research Foundation (US) | 2010-08-11 | — | — | EP | disclosed |
| WO-2009062084-A3 | CLEAVABLE MODIFICATIONS TO REDUCIBLE POLY(AMIDO ETHYLENIMINE)S TO ENHANCE NUCLEOTIDE DELIVERY | UNIV UTAH RES FOUND (US) | 2009-08-13 | — | — | WO | disclosed |
| WO-2009062084-A2 | CLEAVABLE MODIFICATIONS TO REDUCIBLE POLY(AMIDO ETHYLENIMINE)S TO ENHANCE NUCLEOTIDE DELIVERY | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2009-05-14 | — | — | WO | disclosed |
| EP-1233944-B1 | COUPLING CONDENSATION SYNTHESIS OF HETEROCYCLES | MORPHOCHEM AG (DE) | 2004-03-31 | — | — | EP | disclosed |
| WO-2004013207-A1 | POLYMETHYLENE AMINE, METHOD FOR THE PRODUCTION AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2004-02-12 | — | — | WO | disclosed |